At SyntheX, we are harnessing evolution in our synthetic biology based selection platforms, ToRPPIDO and ToRNeDO, to create and identify molecules that disrupt or bridge previously 'undruggable' protein-protein interactions for therapeutic and biotechnological applications.

We identify relevant drug targets based on clinical, evolutionary, and phenotypic features.

Using our evolutionary cell-based platform, we select targeted compounds that modulate protein-protein interactions.


  • Twitter
  • LinkedIn Social Icon

© 2020 by SyntheX